Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.

Our fair value estimate for WuXi is HKD 24.60 per share. WuXi has been growing at a CAGR of 53.3% for the past eight years. Although its USD 20.5 billion total backlog revenue supports our growth ...

On Tuesday, January 7, the FDA announced it would now be requiring GSK and Pfizer’s RSV vaccines to hold warnings of a risk ...

Bagsværd, Denmark Friday, January 10, 2025, 11:00 Hrs [IST] ...

With the intensification of global population aging, muscle atrophy, characterized by the loss of muscle mass and function, ...

UK Biobank's proteomics study will measure 5,400 proteins in 600,000 samples, tracking changes over mid-to-late life. By ...

A new era, where AI is at the centre of the drug discovery process is emerging, says Charlotte Deane, a professor of ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

Allison Holker says in a new interview that she made an "alarming" discovery shortly after her late husband, Stephen "tWitch" Boss, died by suicide in December 2022.

Scientists have long considered ketones (a fundamental chemical class) and esters (molecules formed when an acid reacts with ...

The global biotechnology industry market size is projected to expand from USD 483.0 billion in 2024 to USD 546.0 billion by ...

By mid-2025, the biotech will split into two entities: a new, as-yet-unnamed innovative medicines specialist and a cell ...